Study points toward an alternative drug strategy to stall Al

Boosting levels of the neurotransmitter norepinephrine with atomoxetine, a repurposed ADHD medication, may be able to stall neurodegeneration in people with early signs of Alzheimer's disease, a study conducted at Emory Brain Health Center suggests.

Related Keywords

Allan Levey , David Weinshenker , Emily Henderson , Emory Brain Health Center , National Institutes Of Health , Emory University School Of Medicine , Alzheimer Drug Discovery Foundation , Alzheimer Association , Goizueta Institute Emory Brain Health , Emory University School , Goizueta Institute , Emory Brain , National Institutes , Drug Discovery Foundation , Kenan Family , Drug Discovery , Neurodegeneration , Lzheimer 39s Disease , Antibodies , Atomoxetine , Rain , Maging , Inflammation , Focus , Medicine , Norepinephrine , Pathology , Placebo , Protein , Research ,